<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27534269</article-id>
<article-id pub-id-type="pmc">5143489</article-id>
<article-id pub-id-type="pii">npp2016158</article-id>
<article-id pub-id-type="doi">10.1038/npp.2016.158</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuropsychopharmacology Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of the Immune System in Autism Spectrum Disorder</article-title>
<alt-title alt-title-type="running">The immune system and autism</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Meltzer</surname>
<given-names>Amory</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van de Water</surname>
<given-names>Judy</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Division of Rheumatology/Allergy and Clinical Immunology, Department of Internal Medicine, University of California</institution>, Davis, CA, <country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>The M.I.N.D. Institute, University of California</institution>, Davis, CA, <country>USA</country></aff>
<aff id="aff3"><label>3</label><institution>NIEHS Center for Children's Environmental Health, University of California</institution>, Davis, CA, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Division of Rheumatology/Allergy and Clinical Immunology</institution>; 451 E. Health Sciences Dr, Suite 6510; University of California Davis, Davis, CA 95616, <country>USA</country>, Tel: +1 530 752 2154, Fax: +1 530 752 4669, E-mail: <email>javandewater@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>18</day>
<month>08</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2016</year>
</pub-date>
<volume>42</volume>
<issue>1</issue>
<fpage>284</fpage>
<lpage>298</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>08</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>08</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2017 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Autism is a neurodevelopmental disorder characterized by deficits in communication and social skills as well as repetitive and stereotypical behaviors. While much effort has focused on the identification of genes associated with autism, research emerging within the past two decades suggests that immune dysfunction is a viable risk factor contributing to the neurodevelopmental deficits observed in autism spectrum disorders (ASD). Further, it is the heterogeneity within this disorder that has brought to light much of the current thinking regarding the subphenotypes within ASD and how the immune system is associated with these distinctions. This review will focus on the two main axes of immune involvement in ASD, namely dysfunction in the prenatal and postnatal periods. During gestation, prenatal insults including maternal infection and subsequent immunological activation may increase the risk of autism in the child. Similarly, the presence of maternally derived anti-brain autoantibodies found in ~20% of mothers whose children are at risk for developing autism has defined an additional subphenotype of ASD. The postnatal environment, on the other hand, is characterized by related but distinct profiles of immune dysregulation, inflammation, and endogenous autoantibodies that all persist within the affected individual. Further definition of the role of immune dysregulation in ASD thus necessitates a deeper understanding of the interaction between both maternal and child immune systems, and the role they have in diagnosis and treatment.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>